Notebook

Twenty-five years after the notorious Tuskegee study came to light, the United States government will formally apologize to its unwitting participants. The White House announced in early April that President Clinton soon would issue an apology to the 399 African American men whose syphilis was observed from 1932 to 1972 as part of an experiment by the U.S. Public Health Service. Despite the discovery in 1947 that penicillin cures syphilis, researchers neither treated the men nor told them they

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Twenty-five years after the notorious Tuskegee study came to light, the United States government will formally apologize to its unwitting participants. The White House announced in early April that President Clinton soon would issue an apology to the 399 African American men whose syphilis was observed from 1932 to 1972 as part of an experiment by the U.S. Public Health Service. Despite the discovery in 1947 that penicillin cures syphilis, researchers neither treated the men nor told them they had the disease. The study is often cited as a primary reason for minority people's mistrust of science and scientists (T.W. Durso, The Scientist, Feb. 17, 1997, page 1), and observers feel an apology should help rebuild trust. "For the president to say that this has been an affront against part of the human race is really important qualitatively, because it makes a threshold after which nobody can deny that this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies